InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-24.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Stevens John Henry, Director. Officer active across 1 company, notably Clene Inc.. Cumulatively, 7 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €564k. Activity tracked since 14 July 2021. The latest transaction was disclosed on 26 June 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
316,455 shares@ US$0.8028.3% of flowCommon StockSEC:0001562180-23-005507:0
Ideal exit: 22 Mar 2024 (T+270)
148,515 shares@ US$1.0118.5% of flowCommon StockSEC:0001562180-22-007454:0
Ideal exit: 30 Jul 2023 (T+270)
47,662 shares@ US$3.8522.0% of flowCommon StockSEC:0001562180-22-006207:0
Ideal exit: 14 May 2023 (T+270)
273,194 shares@ US$0.530.20% mcap100.0% of flowCommon StockSEC:0001562180-22-001623
273,194 shares@ US$0.530.20% mcap50.0% of flowCommon StockSEC:0001562180-22-001623:0
14,378 shares0Common StockSEC:0001562180-21-004955
14,378 shares0Common StockSEC:0001562180-21-004955:0
7 of 7 declarations
About Stevens John Henry
John Henry Stevens is a Director at Clene Inc. As a board member, he plays a key role in the governance of the company, providing his expertise and strategic advice. John Henry is involved in making important decisions that influence the direction of Clene Inc., contributing to its development and growth in the biotechnology sector. His diverse experience enriches discussions within the board.
